J Korean Assoc Oral Maxillofac Surg.  2012 Feb;38(1):20-28. 10.5125/jkaoms.2012.38.1.20.

Oral cancer incidence based on annual cancer statistics in Korea

• Sun JR
• Kim SM
• Seo MH
• Kim MJ
• Lee JH
• Myoung H

• KMID: 1434375
• DOI: http://doi.org/10.5125/jkaoms.2012.38.1.20

Abstract

INTRODUCTION
The objective of this research was to determine the incidence of oral cancer in Korea.
MATERIALS AND METHODS
The classifications of oral and maxillofacial cancer (OMFC) that we used are based on possible locations of OMFC: lip, tongue, mouth, salivary glands, tonsil, oropharynx, nasopharynx, hypopharynx, pharynx unspecified, and nose, sinuses.
RESULTS
1) There were 2,848 OMFC cases, accounting for 1.6% of all cancers. The male to female ratio was 2.72:1. 2) The estimated crude rates (CRs) were 5.7 overall, 8.4 for males, and 3.1 for females. The age-standardized incidence rates (ASRs) were 4.6 overall, 7.3 for males and 2.3 for females. 3) The incidence of mouth cancer was highest. The mouth and salivary glands were the most frequent sites for cancer among males and females, respectively. 4) Patients who were 40 years or older accounted for 91% of OMFC cases, with the highest proportion of cases in the 60-69 year-old age group for both sexes. 5) Tongue cancer was the most prevalent OMFC overall. Nasopharyngeal cancer was highest among males, and salivary gland cancer was highest among females. 6) From 2004 to 2008, the relative 5-year survival rate of OMFC patients was 57.5%. There was a trend of increasing survival among OMFC patients during the study period. The survival rate for females (69.3%) was much higher than that for males (53.1%).
CONCLUSION
Social and personal efforts should be required to increase the survival rates of OMFC patients and Korean national cancer management policy should establish new measures for economic and social management and support.

Keyword

Age-standardized incidence rates; Estimated crude rate; Oral and maxillofacial cancer; Oral cancer incidence; Relative 5-year survival rate

MeSH Terms

Accounting
Female
Humans
Hypopharynx
Incidence
Korea
Lip
Male
Mouth
Mouth Neoplasms
Nasopharyngeal Neoplasms
Nasopharynx
Nose
Oropharynx
Palatine Tonsil
Pharynx
Salivary Gland Neoplasms
Salivary Glands
Survival Rate
Tongue
Tongue Neoplasms

Reference

1. Korea Statistical Information System (KOSIS), On-line publication, Social indicator of Korea [Internet]. Statistics Korea. cited 2011 Jul 22. Available from: http://kosis.kr.

2. Korea statistical Information System (KOSIS), Online publication, Death reason statistics [Internet]. Statistic Korea. cited 2011 Jul 22. Available from: http://kosis.kr.

3. National Cancer Center, Korea Central Cancer Registry, Information, Annual report of cancer statistics [Internet]. Korea Central Cancer Registry. cited 2011 Jul 01. Available from: http://ncc.re.kr.

4. Parkin DM, Pisani P, Ferlay J. Estimates of the worldwide incidence of 25 major cancers in 1990. Int J Cancer. 1999. 80:827–841.

5. Brent BW, Joseph IH. Fonseca RJ, editor. Squamous cell carcinoma of the oral nad maxillofacial region. Oral and maxillofacial surgery. 2009. 2nd ed. St. Louis (MO): Saunders;705–723.

6. Arbes SJ Jr, Olshan AF, Caplan DJ, Schoenbach VJ, Slade GD, Symons MJ. Factors contributing to the poorer survival of black Americans diagnosed with oral cancer (United States). Cancer Causes Control. 1999. 10:513–523.

7. Shiboski CH, Shiboski SC, Silverman S Jr. Trends in oral cancer rates in the United States, 1973-1996. Community Dent Oral Epidemiol. 2000. 28:249–256.

8. Bray F, Sankila R, Ferlay J, Parkin DM. Estimates of cancer incidence and mortality in Europe in 1995. Eur J Cancer. 2002. 38:99–166.

9. Funk GF, Karnell LH, Robinson RA, Zhen WK, Trask DK, Hoffman HT. Presentation, treatment, and outcome of oral cavity cancer: a National Cancer Data Base report. Head Neck. 2002. 24:165–180.

10. Abreu LP, Kruger E, Tennant M. Oral cancer in Western Australia, 1982-2006: a retrospective epidemiological study. J Oral Pathol Med. 2010. 39:376–381.

11. Kim MY, Kim CS, Lee SH, Kim JW, Jang HJ. A clinicostatistical analysis of oral cancer patients for recent 8 years. J Korean Assoc Oral Maxillofac Surg. 2007. 33:660–668.

12. Cho BH, Min SK, Oh SH, Lee DK, Kim YG. Retrospective study on the influencing factors of survival rate after treatments of oral cancer. J Korean Assoc Maxillofac Plast Reconstr Surg. 2002. 24:211–217.

13. Chandu A, Adams G, Smith AC. Factors affecting survival in patients with oral cancer: an Australian perspective. Int J Oral Maxillofac Surg. 2005. 34:514–520.

14. Warnakulasuriya S. Global epidemiology of oral and oropharyngeal cancer. Oral Oncol. 2009. 45:309–316.

15. Zini A, Czerninski R, Vered Y, Livny A, Sgan-Cohen HD. Trends of oral and pharyngeal cancer in Israel, by gender, age, ethnic group, and country of origin: 1970-2006. Community Dent Oral Epidemiol. 2009. 37:547–554.

16. Bjørndal K, Krogdahl A, Therkildsen MH, Overgaard J, Johansen J, Kristensen CA, et al. Salivary gland carcinoma in Denmark 1990-2005: a national study of incidence, site and histology. Results of the Danish Head and Neck Cancer Group (DAHANCA). Oral Oncol. 2011. 47:677–682.

17. Layland MK, Sessions DG, Lenox J. The influence of lymph node metastasis in the treatment of squamous cell carcinoma of the oral cavity, oropharynx, larynx, and hypopharynx: N0 versus N+. Laryngoscope. 2005. 115:629–639.

18. Blot WJ, McLaughlin JK, Winn DM, Austin DF, Greenberg RS, Preston-Martin S, et al. Smoking and drinking in relation to oral and pharyngeal cancer. Cancer Res. 1988. 48:3282–3287.

19. Kwon HK, Cha IH, Lim SJ, Choi CH, Kim BI. Risk factors for oral cancer: a case-control study. J Korean Assoc Oral Maxillofac Surg. 2002. 28:395–400.

20. Llewellyn CD, Johnson NW, Warnakulasuriya KA. Risk factors for squamous cell carcinoma of the oral cavity in young people--a comprehensive literature review. Oral Oncol. 2001. 37:401–418.

21. La Vecchia C, Tavani A, Franceschi S, Levi F, Corrao G, Negri E. Epidemiology and prevention of oral cancer. Oral Oncol. 1997. 33:302–312.

22. Xi S, Grandis JR. Gene therapy for the treatment of oral squamous cell carcinoma. J Dent Res. 2003. 82:11–16.

23. Nagano H, Deguchi K, Kurono Y. Malignant fibrous histiocytoma of the bucca: a case report. Auris Nasus Larynx. 2008. 35:165–169.